Recent advances in identifying and utilizing metabolites of selected doping agents in human sports drug testing

Publication: Contribution to journalScientific review articlesResearch

Abstract

Probing for evidence of the administration of prohibited therapeutics, drugs and/or drug candidates as well as the use of methods of doping in doping control samples is a central assignment of anti-doping laboratories. In order to accomplish the desired analytical sensitivity, retrospectivity, and comprehensiveness, a considerable portion of anti-doping research has been invested into studying metabolic biotransformation and elimination profiles of doping agents. As these doping agents include lower molecular mass drugs such as e.g. stimulants and anabolic androgenic steroids, some of which further necessitate the differentiation of their natural/endogenous or xenobiotic origin, but also higher molecular mass substances such as e.g. insulins, growth hormone, or siRNA/anti-sense oligonucleotides, a variety of different strategies towards the identification of employable and informative metabolites have been developed. In this review, approaches supporting the identification, characterization, and implementation of metabolites exemplified by means of selected doping agents into routine doping controls are presented, and challenges as well as solutions reported and published between 2010 and 2020 are discussed.

Original languageEnglish
Article number114312
JournalJournal of pharmaceutical and biomedical analysis
Volume205
ISSN0731-7085
DOIs
Publication statusPublished - 25.10.2021

Research areas and keywords

  • Anabolic Agents
  • Doping in Sports
  • Humans
  • Pharmaceutical Preparations
  • Sports
  • Substance Abuse Detection

Fingerprint

Dive into the research topics of 'Recent advances in identifying and utilizing metabolites of selected doping agents in human sports drug testing'. Together they form a unique fingerprint.

Citation